MET vs TERN · P/E 13, $52.16B cap vs $6.12B cap
MetLife Inc (MET) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
MET does not have a complete income-statement cache yet.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
MET currently screens at market cap $52.16B and trailing P/E 12.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the MET and TERN stock pages for the full models.
Not investment advice.